Seoul, South Korea

Seung Hee Ji


 

 

Average Co-Inventor Count = 9.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Seung Hee Ji: Innovator in Pharmaceutical Chemistry

Introduction

Seung Hee Ji is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Ji's work focuses on developing novel compounds that have potential therapeutic applications.

Latest Patents

One of Ji's latest patents is for aminoalkylbenzothiazepine derivatives and their uses. This invention relates to a novel aminoalkylbenzothiazepine derivative or a pharmaceutically acceptable salt thereof. It also includes a pharmaceutical composition for preventing or treating constipation, which comprises this compound as an active ingredient. Another significant patent is for a protein kinase inhibitor containing a pyrrolopyridazine derivative. This invention describes a pyrrolopyridazine derivative that can inhibit the activity of protein kinase(s), making it useful for preventing or treating related diseases.

Career Highlights

Throughout his career, Seung Hee Ji has worked with notable organizations, including CJ Healthcare Corporation and The Asan Foundation. His experience in these companies has allowed him to apply his innovative ideas in practical settings, contributing to advancements in healthcare.

Collaborations

Ji has collaborated with several professionals in his field, including Won-Hyuk Jung and Seung In Kim. These collaborations have further enriched his research and development efforts.

Conclusion

Seung Hee Ji is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a commitment to addressing medical challenges through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…